BCAB BioAtla, Inc. logo

BCAB BioAtla, Inc.

Healthcare
$3.69+2.07%ClosedMarket Cap: $4.7M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$250.00

Target (Median)

$250.00

Target Range

$250.00 - $250.00

Upside from current price: 6675.1%

Rating Distribution

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-08-13JMP SecuritiesdowngradeMarket PerformMarket Outperform
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-46.00$19.7M1
Fri Dec 31$-58.50$3.6M1
Sun Dec 31$-45.00$54.6M1
Mon Dec 31$-48.00$239.4M1